Towards Biomedical Superintelligence: from AI agents to AI innovators

Khartis Therapeutics Emerges with $50M Series B for Thyroid Eye Disease Treatment

Prometheus, Jeff Bezos’ AI startup, is now worth $41 billion

UCB to Acquire Candid Therapeutics

Building Bold Companies

Alumis soars as TYK2 drug hits mark in psoriasis trials

Xaira Therapeutics Releases Largest Perturb-Seq Dataset to Power the Virtual Cell

How AI Will Transform Drug Discovery with Foresite Labs CEO Vik Bajaj

Q&A: Project Stargate and the viability of AI cancer vaccines

AI-based predictive biology coming soon, Foresite’s Bajaj says